CD44 and neoplasm: Moreover, we explored the GEPIA tool and Human Protein Atlas (HPA) database for immunohistochemistry (IHC) (HPA; www.proteinatlas.org/, 27 March 2021), to compare the expression levels of CCND1, PLK1, and CD44 between tumor samples and normal samples.